Treatment options and pricing
Browse and click below to book any of our available service.
Recurrent Urinary Tract Infection UTI Vaccine: Follow up Consultation
Included in the Recurrent Urinary Tract Infection UTI Vaccine: Follow up Consultation
In a follow-up urogynecology consultation, you’ll meet with the specialist to discuss the results of any treatments or interventions, evaluate your urogynecological health progress, and make any necessary modifications to your ongoing care plan.
Recurrent Urinary Tract Infection UTI Vaccine: Initial Consultation
Included in the Recurrent Urinary Tract Infection UTI Vaccine: Initial Consultation
During the initial urogynecology consultation, you’ll consult with a specialised medical professional who will address your pelvic health concerns, review your medical history, and potentially recommend further assessments or treatments tailored to your individual needs. If required, Midstream urine (MSU) culture: £31.
Common Q&A about Recurrent Urinary Tract Infection UTI Vaccine
Our FAQ section is designed to address common questions you may have, from how our treatments work to what you can expect during and after your session.
Our team is always available to provide additional support if you need more personalised guidance, ensuring that you feel informed and confident every step of the way.
A recurrent UTI vaccine is designed to help prevent repeated urinary tract infections by stimulating the body’s immune system to fight off the bacteria that typically cause UTIs, such as Escherichia coli (E. coli).
The vaccine targets the bacteria responsible for most UTIs, encouraging the immune system to recognize and destroy these bacteria before they can cause an infection, reducing the frequency of recurrent UTIs.
The vaccine is primarily aimed at individuals who suffer from recurrent UTIs, which are defined as having three or more infections in 12 months, or two infections within six months.
As of now, recurrent UTI vaccines are still under development or in clinical trials. Some early versions are available in certain countries, but widespread availability is limited. It’s important to consult your doctor for current treatment options.
Early studies have shown promising results in reducing the frequency of recurrent UTIs. However, effectiveness can vary from person to person, and more research is ongoing to determine long-term outcomes.
The UTI vaccine is typically administered through an injection. Some vaccines in development may involve a series of injections over a period of weeks or months to build up immunity.
Common side effects of the UTI vaccine may include mild redness or swelling at the injection site, fever, or fatigue. More serious side effects are rare, but it's important to discuss any concerns with Us.
The vaccine is designed to reduce the need for antibiotics by preventing recurrent infections. However, antibiotics may still be needed to treat acute UTIs. The goal of the vaccine is to lower the frequency of infections and reduce antibiotic resistance.
The duration of protection from a UTI vaccine is still being studied. Some vaccines may offer protection for several months to years, but booster doses may be required to maintain immunity.
Yes, current alternatives include prophylactic antibiotics, lifestyle changes (increased hydration, proper hygiene), cranberry supplements, and intravaginal estrogen for postmenopausal women. The vaccine represents a potential new approach for those not responding to these options.
